Poland· PL-100279921
Cetraxal
A ciprofloxacin product containing ciprofloxacinum, registered in Poland by Tactica Pharmaceuticals Sp. z o.o.. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Ciprofloxacin is registered in 10 of 19 countries.
Countries holding a registration under ATC S02AA15 (ciprofloxacin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Ciprofloxacin · ATC S02AA15
10 / 19 countries
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Ciprofloxacinum
- Manufacturer
- Tactica Pharmaceuticals Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- S02AA15
- ATC class
- Ciprofloxacin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990978649
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ciprofloxacin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCiprofloxacin OticGenus Lifesciences
- FinlandCetraxalPOA Pharma Scandinavia AB
- IcelandCetraxalPOA Pharma Scandinavia AB
- NetherlandsCetraxal 2 mg/ml oordruppels, oplossingLaboratorios SALVAT, S.A.
- NorwayCetraxalPOA Pharma Scandinavia AB
- SwedenCetraxal 2 mg/ml Örondroppar, lösning i endosbehållarePOA Pharma Scandinavia AB
- United KingdomCetraxal 2mg/ml ear drops 0.25ml unit doseAspire Pharma Ltd
- ItalyBASEMARN.I. PHARMA S.R.L.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Ciflox, Ciloxan
- Belgium · Ciloxan, Ciprofloxacine Ab
- Bulgaria · Ciprofloxacin World Medicine Europe Eood, Орпикс
- Cyprus · Cifloxacin, Ciloxan
- Czechia · Cifloxinal, Ciloxan
- Germany · Ciloxan, Cipro
- Denmark · Cetraxal, Cifin
- Estonia · Ciloxan, Ciprinol
- Spain · Aceoto, Cetraflux
- Finland · Cetraxal, Ciprofloxacin Fresenius Kab
- France · Ciflox, Ciloxan
- United Kingdom (Northern Ireland) · Cetraxal, Ciloxan
- Greece · Aristin-C, Bivorilan
- Croatia · Ciflox, Ciloxan
- Hungary · Cifloxin, Cifran
- Ireland · Cifloxager, Cifox
- Iceland · Cetraxal, Ciprofloxacin Alvogen
- Italy · Basemar 250 Mg, Basemar 500 Mg
- Lithuania · Cifran, Ciloxan
- Luxembourg · Ciloxan, Ciprofloxacin Kabi
- Latvia · Cifran, Ciloxan
- Malta · Aristin-C, Cifox
- Netherlands · Cetraxal, Ciprinol
- Norway · Cetraxal, Cilox
- Portugal · Cetraflux, Ciplox
- Romania · Cifran, Ciprinol
- Sweden · Cetraxal, Ciloxan
- Slovenia · Ciloxan, Ciprinol
- Slovakia · Ciphin, Ciprinol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a241ec44-11da-44c3-bf94-69d8f78a484c GET /v1/drugs/a241ec44-11da-44c3-bf94-69d8f78a484c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do uszu, roztwór",
"source": "urpl",
"strength": "2 mg/ml",
"packaging": "05909990978649 ¦ Rp ¦ 76758\n15 amp. 0,25 ml",
"substance": "Ciprofloxacinum 2 mg/ml",
"common_name": "Ciprofloxacinum",
"pl_product_id": "100279921",
"pozwolenie_nr": "20161",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about ciprofloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.